Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.710
+0.140 (5.45%)
Jun 2, 2026, 1:45 PM EDT - Market open
Fortress Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 66.16 | 63.26 | 57.68 | 84.51 | 75.74 | 68.79 | |
Revenue Growth (YoY) | 14.50% | 9.69% | -31.76% | 11.58% | 10.11% | 50.86% |
Cost of Revenue | 22.35 | 20.92 | 20.88 | 22.89 | 30.78 | 32.08 |
Gross Profit | 43.81 | 42.34 | 36.8 | 61.62 | 44.97 | 36.71 |
Selling, General & Admin | 86.8 | 96.4 | 87.73 | 90.98 | 113.66 | 86.84 |
Depreciation & Amortization Expenses | 4.32 | 4.26 | 3.42 | 3.77 | - | - |
Research & Development | 8.51 | 11.9 | 56.88 | 106.07 | 134.88 | 128.87 |
Other Operating Expenses | - | - | 8.25 | 3.14 | - | 9.54 |
Total Operating Expenses | 99.62 | 112.56 | 156.28 | 203.96 | 248.53 | 225.25 |
Operating Income | -55.81 | -70.22 | -110.38 | -142.34 | -203.56 | -188.54 |
Interest Income | 2.57 | 2.49 | 2.68 | 3 | 1.4 | 0.65 |
Interest Expense | -10.67 | -10.11 | -13.53 | -15.32 | -13.64 | -15.31 |
Other Non-Operating Income (Expense) | 197.2 | 44.31 | 0.68 | 1.02 | 2.34 | 38.85 |
Total Non-Operating Income (Expense) | 189.09 | 36.69 | -10.16 | -11.29 | -9.9 | 24.19 |
Pretax Income | 144.93 | -33.54 | -120.54 | -153.63 | -213.46 | -164.35 |
Provision for Income Taxes | 4.34 | -0.62 | 0.31 | 0.52 | 0.45 | 0.47 |
Net Income | 125.4 | -1.88 | -55.89 | -68.67 | -94.61 | -64.7 |
Minority Interest in Earnings | 1.17 | -39.73 | -74.86 | -93.52 | -127.34 | -100.12 |
Net Income Attributable to Preferred Dividends | 6.44 | 8.7 | 9.89 | 8.03 | 8.03 | - |
Net Income to Common | 125.4 | -1.88 | -55.89 | -68.67 | -94.61 | -64.7 |
Shares Outstanding (Basic) | 29 | 28 | 21 | 8 | 6 | 5 |
Shares Outstanding (Diluted) | 30 | 28 | 21 | 8 | 6 | 5 |
Shares Change (YoY) | 33.58% | 34.24% | 156.25% | 36.89% | 8.78% | 13.46% |
EPS (Basic) | 3.84 | -0.07 | -2.69 | -8.47 | -15.97 | -11.85 |
EPS (Diluted) | 3.17 | -0.07 | -2.69 | -8.47 | -15.97 | -11.85 |
Shares Outstanding | 33.19 | 31.36 | 27.91 | 15.09 | 7.37 | 6.76 |
Free Cash Flow | 157.64 | -65.78 | -80.19 | -128.29 | -182.12 | -121.11 |
Free Cash Flow Per Share | 5.22 | -2.36 | -3.86 | -15.82 | -30.74 | -22.23 |
Gross Margin | 66.22% | 66.92% | 63.80% | 72.91% | 59.37% | 53.36% |
Operating Margin | -84.36% | -111.00% | -191.38% | -168.43% | -268.76% | -274.08% |
Profit Margin | 194.88% | -52.03% | -209.55% | -182.40% | -282.42% | -239.60% |
FCF Margin | 238.26% | -103.98% | -139.04% | -151.80% | -240.44% | -176.05% |
EBITDA | -49.19 | -63.62 | -103.07 | -134.27 | -194.21 | -184.22 |
EBITDA Margin | -74.34% | -100.56% | -178.71% | -158.87% | -256.41% | -267.80% |
EBIT | -55.81 | -70.22 | -110.38 | -142.34 | -203.56 | -188.54 |
EBIT Margin | -84.36% | -111.00% | -191.38% | -168.43% | -268.76% | -274.08% |
Effective Tax Rate | 3.00% | 1.85% | -0.26% | -0.34% | -0.21% | -0.29% |